Freeze Tag, Inc. FRZT Company Overview Stock Message

New Post Public Reply Private Reply Replies (0) Message Board

Aug 31, 2013 at 12:22 PM

Freeze Tag, Inc. FRZT Company Overview

Stock Message Board http://investorshangout.com/search?q=FRZT&...mp;yt1=Go!

Freeze Tag, Inc. FRZT Current Price and Quotes
0.0027
Previous Close
0.0022
Open
0.0027

Daily Range
0.0027 - 0.0027
52wk Range
0.043 - 0.001

Volume
4,000
Dividend
N/A

Average Vol (3m)
416,811
Yield
N/A

Freeze Tag, Inc. FRZT
Company Information
228 W. Main Street
2nd Floor
Tustin, CA 92780

Website: http://www.freezetag.com
Phone: 714-210-3850
Find us on:

Freeze Tag, Inc. FRZT
The Company develops family-friendly casual games for tablets and smartphones. The Company's core belief is that games should be enjoyed as a family activity, and not limited to any one demographic. The Company focuses on casual games because it believes that these games have a wider appeal to the majority of the population, which means that the Company's revenue potential is large. The Company targets mobile devices, such as tablets and smartphones, because research shows that more games are b...

Freeze Tag, Inc. FRZT
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001485074
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 7372 - Prepackaged software
Incorporated In: DE, USA
Year of Inc. 2006
Employees 14 a/o Jun 06, 2011
Company Officers/Contacts
Craig Holland President, CEO, Chief Creative Officer
Mick Donahoo COO, CFO, Secretary
Company Directors
Mick Donahoo
Craig Holland
Service Providers
Auditor/Accountant
M&K CPAS, PLLC
4100 North Sam Houston Pkwy W
Houston, TX, 77086
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available

Freeze Tag, Inc. FRZT
FRZT Security Details
Share Structure
Market Value1 $209,856 a/o Aug 30, 2013
Shares Outstanding 77,724,404 a/o Aug 12, 2013
Float Not Available
Authorized Shares 100,000,000 a/o Aug 15, 2011
Par Value 0.001
Shareholders
Shareholders of Record 127 a/o Apr 01, 2013
Short Selling Data
Short Interest 0 (-100%)
May 15, 2013
Significant Failures to Deliver No
Transfer Agent(s)
Colonial Stock Transfer Co., Inc.

Freeze Tag, Inc. FRZT Recent News

Freeze Tag, Inc. FRZT Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 449 733 644 865
Cost of Revenue 440 373 458 743
Gross Profit 9 360 186 123
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 842 518 336 322
Non-Recurring Items - - - -
Other 93 51 - 3
Operating Income (926) (209) (151) (203)
Income From Continuing Operations
Add'l Income/Expense Items (35) - - (30)
Earnings Before Interest and Tax (1,018) (227) (161) (233)
Interest Expense - - - -
Earnings Before Tax (1,018) (227) (161) (233)
Income Tax 1 3 1 1
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (1,054) (230) (162) (234)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,020) (230) (162) (234)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (1,020) (230) (162) (234)

FRZT Freeze Tag, Inc. Research DD Guide

FRZT Freeze Tag, Inc. Stock Message Board http://investorshangout.com/search?q=FRZT&...mp;yt0=Go!
FRZT Freeze Tag, Inc. Stock Quote http://www.otcmarkets.com/stock/FRZT/quote
FRZT Freeze Tag, Inc. Stock Chart http://www.otcmarkets.com/stock/FRZT/chart
FRZT Freeze Tag, Inc. Company Info http://www.otcmarkets.com/stock/FRZT/company-info
FRZT Freeze Tag, Inc. Recent News http://www.otcmarkets.com/stock/FRZT/news
FRZT Freeze Tag, Inc. Financials http://www.otcmarkets.com/stock/FRZT/financials
FRZT Freeze Tag, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/FRZT/filings
FRZT Freeze Tag, Inc. Short Sales http://www.otcmarkets.com/stock/FRZT/short-sales
FRZT Freeze Tag, Inc. Insider Disclosure http://www.otcmarkets.com/stock/FRZT/insider-transactions
FRZT Freeze Tag, Inc. Research Reports http://www.otcmarkets.com/stock/FRZT/research
FRZT Freeze Tag, Inc. Summary http://finance.yahoo.com/q?s=FRZT
FRZT Freeze Tag, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=FRZT+Historical+Prices
FRZT Freeze Tag, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=FRZT
FRZT Freeze Tag, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=FRZT+Basic+Chart
FRZT Freeze Tag, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=FRZT+Basic+Tech.+Analysis
FRZT Freeze Tag, Inc. Headlines http://finance.yahoo.com/q/h?s=FRZT+Headlines
FRZT Freeze Tag, Inc. Press Releases http://finance.yahoo.com/q/p?s=FRZT+Press+Releases
FRZT Freeze Tag, Inc. Company Profile http://finance.yahoo.com/q/pr?s=FRZT+Profile
FRZT Freeze Tag, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=FRZT+Key+Statistics
FRZT Freeze Tag, Inc. Industry http://finance.yahoo.com/q/in?s=FRZT+Industry
FRZT Freeze Tag, Inc. Major Holders http://finance.yahoo.com/q/mh?s=FRZT+Major+Holders
FRZT Freeze Tag, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=FRZT+Insider+Transactions
FRZT Freeze Tag, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=FRZT+Insider+Roster
FRZT Freeze Tag, Inc. Income Statement http://finance.yahoo.com/q/is?s=FRZT
FRZT Freeze Tag, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=FRZT
FRZT Freeze Tag, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=FRZT+Cash+Flow&annual
FRZT Freeze Tag, Inc. Nasdaq http://www.nasdaq.com/symbol/FRZT
FRZT Freeze Tag, Inc. Market Watch http://www.marketwatch.com/investing/stock/FRZT
FRZT Freeze Tag, Inc. Bloomberg http://www.bloomberg.com/quote/FRZT:US
FRZT Freeze Tag, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=FRZT
FRZT Freeze Tag, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=FRZT
FRZT Freeze Tag, Inc. Barchart http://www.barchart.com/quotes/stocks/FRZT
FRZT Freeze Tag, Inc. OTC Short Report http://otcshortreport.com/index.php?index=FRZT
FRZT Freeze Tag, Inc. Investopedia http://www.investopedia.com/markets/stocks/FRZT/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Southern Company Sparks Swift Power Restoration Post-Isaias

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

NARUTO Card Game Set for June 2027 Global Launch

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

AI Drives Major Time Savings in Endoscopy Tech

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...